COMMUNIQUÉS West-GlobeNewswire

CTV Toronto Highlights FSD Pharma’s Cobourg Facility -- CFN Media
18/10/2018
SEATTLE, Oct. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Predictive Technology Group Appoints Charles Andres to Its Scientific Advisory Board
18/10/2018
SALT LAKE CITY, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification and subsequent therapeutic intervention through [...]
Ultragenyx Announces Approval of Mepsevii™ (vestronidase alfa) in Brazil for the Treatment of Mucopolysaccharidosis VII
18/10/2018
Mepsevii, an enzyme replacement therapy, is the first treatment approved in Latin America for this rare genetic disease NOVATO, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a [...]
Intellia Therapeutics Presents New Data in In Vivo and Ex Vivo Programs at the 26th Annual Congress of the European Society of Gene and Cell Therapy
18/10/2018
Intellia scientists present first robust demonstration of CRISPR-mediated insertion of transgenes in the liver Non-human primate data show high correlation achieved between liver edit and reduction of TTR protein High [...]
OpGen Announces Pricing of Public Offering of Common Stock
18/10/2018
GAITHERSBURG, Md., Oct. 18, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) today announced the pricing of an underwritten public offering of approximately 2.2 million shares of its common stock at a public offering [...]
Organovo Announces Release Date for Fiscal Second-Quarter 2019 Financial Results
18/10/2018
SAN DIEGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, November 8, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]
Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer
18/10/2018
NEW YORK and CLEVELAND, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
Progressive Care Inc. Announces Beta Launch of New Proprietary Tele-PharmCo Software Platform for Real-Time Patient-to-Pharmacist Video Interactions
18/10/2018
MIAMI, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced the beta launch of its new proprietary tele-pharmacy software [...]
Evolus to Release Third Quarter 2018 Financial Results on Monday, November 5, 2018
18/10/2018
IRVINE, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced that it will release 2018 third quarter financial results after the close of U.S [...]
swyMed Joins AT&T's FirstNet Dealer Program
18/10/2018
Industry Experts in Public Safety Can Now Market, Promote and Co-Sell FirstNet Services LEXINGTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- swyMed, a provider of industry leading telemedicine and connectivity solutions [...]
Samumed to Present Preclinical Data on SM07883 at the 11th Clinical Trials on Alzheimer’s Disease (CTAD) Congress
18/10/2018
SAN DIEGO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it will present preclinical data on the company’s novel DYRK1A inhibitor, SM07883, a potential first-in-class drug for the treatment of [...]
Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings
18/10/2018
NEWTON, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]
Matinas BioPharma Announces Issuance of Key U.S. Patent for Prescription-Only Next Generation Omega-3 MAT9001 Providing Protection Through 2033
18/10/2018
BEDMINSTER, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, announced today that the U.S. Patent and Trademark Office (“USPTO”) [...]
Spectral Announces Presentation at the European Society of Intensive Care Medicine Oct 22nd and Publication of Overall Results of the EUPHRATES trial in JAMA
18/10/2018
TORONTO, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]
Zosano Pharma to Host Key Opinion Leader Meeting on New Treatments for Migraine and the Migraine Patients’ Perspective
18/10/2018
Live webcast of the event available for analysts and investors FREMONT, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq: ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical [...]
Delcath Announces Enrollment of First Patient in ALIGN Trial
18/10/2018
The University of Tennessee Health Science Center, Methodist University Hospital, and West Cancer Center Begin Treatments in New Registration Trial for Intrahepatic Cholangiocarcinoma NEW YORK, Oct. 18, 2018 (GLOBE [...]
Parkview Health First to Activate New SMART® and FHIR® Technology Standards Through Healthwise
18/10/2018
New FHIR Technology to bring innovative patient education and Engagement capabilities through modern, interoperable technologies BOISE, Idaho, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Parkview Health announced today that it [...]
Opiant Pharmaceuticals Announces Receipt of National Institutes of Health Grant by Walter Reed Army Institute of Research and SUNY Upstate Medical University for Development of a Heroin Vaccine
18/10/2018
SANTA MONICA, Calif., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions and drug overdose, [...]
Innovation Behind Precipio’s ICE-COLD PCR™ Platform Spotlighted in Media
18/10/2018
Articles Highlight Scientific and Economic Advantages Provided by Precipio’s Technology NEW HAVEN, Conn., Oct. 18, 2018 (GLOBE NEWSWIRE) -- The scientific and economic advantages of the proprietary, ultra-sensitive ICE- [...]

Pages